Icon
+91 94997 68112
Login Register

Valcyte - (EQ 450mg BASE; Tablet)

Valganciclovir Hydrochloride Roche
EQ 450mg BASE; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Used in adults to prevent infection with cytomegalovirus (CMV) that may occur after an organ transplant (heart, kidney, or pancreas).
Yes
*************** ***** * **** ** **** ******* ** ****** ‘***. ******* ** *** ***. ******** ***** ***** *********’* ****** ‘*** (******** ** ** **** ****) ** ***** *** ***-********* ** *******, *** **** ***** ******** *** ******** ** ******* *******. ***** ***** & ******* ******* * ********** ******* *** **********'* ***** *** ************, *** *** **** ****** ******* ** ****** *** ******* ******* ** ***** **** ***** **, ****. ***** **** ***** **** ** ******** ** **** ** ****** ** ****** , ****** & ** *****'* **** *** **** ****** (‘***) *** **** ************ *********. ****** ********** ********* * ****** ** *.* ***** *** ******* *** ******* ***** *** ******** ** ***** ** *** *** ******. ***** ** *****’* *** **** ******** *** ******* *** **** ****** *** ****** ******. *** **** ****** ********** *** **** ******* ** ** **** ****. ** ****** **** ******* ** ** ************ **** ****. ** ****** **** **** *** ** *****'* ******** ******* **** *** **** ******* **** ********** ** ******* ***-************. ** ** ********* ** **** **** *** *** ***** *******’* ********* ******** *** **** **** *** ** *** ***** ******.
  1. *** *, **** : ******* ******** ***** **** ***** *** **** *** **** ** ****** *** ****** '****** *** *** ***** *** **** ** *** **** ****.
  2. ***** **, **** : ***** ******** ******** ** *****'* ******* ******* ******* ********* ******** ****** **** ******* ** ************** ***** ** ****** ** ********* ******* *******'* ******** ******* ***** *** ******** *****'* ******.
  3. *** **, **** : ***** **** ******* *** *** **** ** ****** ** *** ******** ***** *** *** ******** ** *** ****** (*****'* **** *** ********** ********* ** **** *******'* ******** *** ** ******).
  4. **** **, **** : *** *.*. ******** ***** *** *** ******** ** *** ****** ***** ****, ****** ***** ****'* ****** ******** *** ****-***** **** ******* ** *****, ******* ************' ******* ******* *** *** ******** *****'* ****** ******.
  5. *** **, **** : **** ****** ******** ***** **** ***** *** **** *** **** ** ****** *********** ****** ** '***.
  6. *** **, **** : ***** **** **** **** ****** **** *** **** ** ****** ** ******** ***** ** ********.
  7. *** **, **** : ***** & ******* ******* * ********** ******* *** **********'* ***** *** ************, *** *** **** ****** ******* ** ****** *** ******* ******* ** ***** **** ***** **, ****.
  8. : ***** ***** **** ***** * ****** ** *********** ********* ********* ************ ** ****** *** ** ****. **** ***** * ****** ** ******* ***** ****'* *********** *********.
  9. *** **, **** : ******** ***** ******* ****'* ****** ** ******* ***** ****'* ************ *********.
  10. ***** **, **** : ********* & ***** ***** * **** ******* ****** ** ******** ***** ** ******** ******** ** ********** ** ****** ***** * **** ** **** ****** '***.
  11. ***** *, **** : ****** ******** ***** **** & ********* ***** *** **** ** ****** **** ****** '***.
  12. *** **, **** : ********* & ***** ***** * **** ******* ****** ** ******** ***** ** ******** ******** ** **********.
  13. *** *, **** : ** *****'* ******** ***** **** ***** *** **** ** **** ****** '***.
  14. *** **, **** : ***** **** ***** * **** ******* ** *****'* ** ******** ***** ** ********.
  15. *** *, **** : ********** **** **. *****'* *** ******* ***** *** ***** ** ********** *** *** *****.
  16. *** **, **** : ********** **** ****** *** ****** *** *******, ***** *** ***** ** ********** *** *** *****.
  17. *** *, **** : **. *****'* *** **** ****** ******** *** *******.

Valcyte - (50 mg/mL for Oral Solution)

Valganciclovir Hydrochloride Hoffmann La Roche
50 mg/mL for Oral Solution
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Valcyte is a cytomegalovirus (CMV) nucleoside analogue DNA polymerase inhibitor indicated for: Adult Patients (1.1) • Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) • Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk Pediatric Patients (1.2) • Prevention of CMV disease in kidney and heart transplant patients at high risk
Yes
Valcyte Patent 1 Patent 2
***** ****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** / ** *** **, **** ******* ******** ******** ** *** **, ****
  1. *** *, **** : ***** ****** ******** ******** ** ***** *** ********* ***** *** **** ** ****** **** *******
  2. *** **, **** : ******** *** ********* **** ***** ** ******* '*** *** '***.
  3. *** *, **** : ******** *** ********* ******* ********** **** ***** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.